Jefferies analyst Akash Tewari downgraded Arvinas (ARVN) to Hold from Buy with a price target of $10, down from $52.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARVN:
- Oppenheimer surprised by ‘hasty’ decision to cull frontline Vepdeg development
- Arvinas reports Q1 EPS $1.14 vs (97c) last year
- Arvinas Showcases Promising Preclinical Data at AACR
- Arvinas reports data from preclinical combination studies of ARV-393
- Arvinas price target lowered to $21 from $65 at Truist